Report updated May 26, 2026
Vivy: GLP1 & GLP 1 Tracker
For individuals prescribed GLP-1 medications like Zepbound, Wegovy, or Ozempic seeking structured health tracking and clinical-led guidance.
Vivy: GLP1 & GLP 1 Tracker is a well-regarded health & fitness app that is available. With a 4.8/5 rating from 653 reviews, it maintains solid user satisfaction.
What is Vivy: GLP1 & GLP 1 Tracker?
Vivy is a doctor-developed health tracking app for GLP-1 medication users on iOS.
Users hire Vivy to manage medication side effects and weight loss progress within a clinically-vetted community, reducing the confusion of self-managed treatment.
Current Momentum
v3.4 · 2mo ago
Maintenance- Maintains consistent clinical-led update cadence.
- Ships community-focused feature iterations.
Active Nemesis
Shotsy GLP-1 Tracker
By Shotsy
Other Rivals
7-Day Rank Pulse 🇺🇸
Health & FitnessNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Dedicated forum for users on GLP-1 medications to share experiences and ask questions
Nutrient tracking via image capture of meals to monitor protein intake
Personalized guidance and check-ins designed by a board-certified obesity medicine doctor
How much does it cost?
- Yearly
- Monthly
Subscription-only model for core features, requiring payment via Apple account with auto-renewal.
Who Built It?
Enrichment in progress
Publisher profile available very soon
What other apps does Vita Intelligence make?
What do users think recently?
Medium confidence · 48 reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a excited sentiment.
Limited review volume (48 reviews). Sentiment analysis will deepen as more data lands.
What is the competitive landscape for Vivy: GLP1 & GLP 1 Tracker?
How's The Health & Fitness Market?
Market outlook for this category
Available very soon
The rivals identified
The Nemesis
Head to Head
Vivy must pivot toward clinical authority and unique educational content to differentiate from Shotsy’s pure-utility dominance.
What sets Vivy: GLP1 & GLP 1 Tracker apart
Doctor-developed positioning builds higher clinical trust compared to Shotsy’s general-purpose utility branding.
Focused, streamlined UX avoids the feature bloat that can overwhelm new GLP-1 users.
What's Shotsy GLP-1 Tracker's Edge
Superior data visualization tools for tracking medication levels over time provide deeper clinical utility.
Extensive Apple Health integration allows for seamless data synchronization with existing user health ecosystems.
Contenders
Inventory management features help users track medication supply levels, preventing missed doses due to stockouts.
Unlimited notification and tracking capabilities provide a flexible, low-barrier entry for medication management.
Long-standing reputation and clinical validation provide a level of security that newer niche apps lack.
Comprehensive medication refill reminders and clinical reporting tools offer a complete end-to-end patient management solution.
Direct Bluetooth device connectivity automates data entry, eliminating manual logging errors for chronic condition management.
Clinical-grade reporting features allow users to export comprehensive data sets directly to their healthcare providers.
AI-powered food scanning reduces friction for users attempting to manage diet alongside GLP-1 medication.
Dedicated injection site rotation tracking addresses a specific pain point for long-term medication adherence.
Peers
Live Activity and Dynamic Island widgets provide real-time, glanceable health data without opening the app.
Integrated community messaging groups foster peer-to-peer support, which is absent in purely clinical tracking apps.
Medicamentos Colsubsidio
★2.8 (3.1K)Colsubsidio
💀This app competes in the broader medication management ecosystem by facilitating pharmacy logistics and appointment booking.
Integrated home delivery scheduling for medications creates a tangible logistical advantage over pure tracking apps.
In-person appointment booking capabilities bridge the gap between digital tracking and physical healthcare services.
Gluroo CGM Watchface
★3.9 (165)Gluroo Imaginations Inc.
Gluroo targets the power-user segment that requires real-time synchronization between CGM data and insulin pump management.
Real-time CGM complications on the watch face provide immediate visibility into critical health metrics.
Advanced synchronization between mobile apps and insulin pumps creates a closed-loop management experience.
Stelo by Dexcom
★2.9 (1.5K)Dexcom
🚀Stelo competes by providing hardware-backed biosensor data, which is the gold standard for metabolic health monitoring.
Direct integration with continuous glucose biosensors offers objective, real-time metabolic data rather than manual logs.
Backed by Dexcom’s established brand and infrastructure, providing a high-trust environment for health-conscious users.
New Kids on the Block
Pill Reminder: Med-Alarm
0Ramkumar Vellaisamy
This newcomer enters the space with a privacy-first approach to medication reminders and history tracking.
Privacy-first architecture ensures sensitive health data remains local, appealing to security-conscious medication users.
Easy GLP 1 Tracker
0Dropouts Technologies LLP
A new entrant focusing on Apple Intelligence and clinical reporting to capture users looking for modern, automated insights.
Leverages Apple Intelligence to provide automated, personalized health insights based on user-logged symptoms and weight.
The outtake for Vivy: GLP1 & GLP 1 Tracker
Strengths to defend, gaps to attack
Core Strengths
- Doctor-developed positioning builds clinical trust
- GLP-1 specific community fosters peer-to-peer retention
Critical Frictions
- Subscription-only model for core features limits top-of-funnel conversion
- Lack of automated device integration increases manual logging friction
Growth Levers
- Integration with wearable biosensors for objective metabolic data
- B2B partnerships with clinics for patient management
Market Threats
- Shotsy’s predictive medication visualization tools
- Apple Health integration dominance by established medical apps
What are the next best moves?
Ship free-tier basic tracking because subscription-only core features limit top-of-funnel conversion → increase install velocity
Subscription-only model for core features is the primary barrier to entry.
Trade-off: Pause the coaching-system expansion — top-of-funnel growth is the current priority.
Integrate Apple Health data sync because lack of automated device integration increases manual logging friction → improve retention
Competitors like Blood Sugar Diary offer automated entry, making manual logging a competitive disadvantage.
Trade-off: Deprioritize the community forum UI refresh — data utility is a higher churn risk.
A counter-intuitive read
The clinical-authority moat is a liability if it prevents the app from adopting the frictionless, automated data-sync standards that users now expect from health-tracking utilities.
Feature Gaps vs Competitors
- Automated device connectivity (available in Blood Sugar Diary but missing here)
- Predictive medication level estimation (available in Shotsy but missing here)
Key Takeaways
Vivy holds a strong clinical niche through doctor-led positioning, but the subscription-only barrier leaves it exposed to utility-first rivals, so the team must prioritize free-tier tracking to drive user acquisition.
Where Is It Heading?
Stable
The GLP-1 tracking market is consolidating around utility-first apps that offer automated data synchronization. Vivy must transition from a manual-entry tool to a clinical data hub to remain relevant, or risk losing its user base to competitors with superior device integration.
High rating consistency indicates the clinical-led value proposition resonates with the core user base, stabilizing retention.
Subscription-only access to core features creates a conversion bottleneck that limits growth against free-to-use utility competitors.